Xingyin Pharmaceutical development is divided into four stages:
Sampan - (1986-1999)
1986
The company introduced the pure plant medicine "Xinnaoling", which was originally produced in Germany, and then changed its name to Xingnaoling tablet.
1989
The company\'s general agent of German original pure plant medicine "strong pulse hemorrhoid", later renamed Mai Zhi Ling tablet.
1994
Shenzhen Star Silver Pharmaceutical Glass Co., Ltd. was officially established.
1995
The company has set up 28 offices across the country, and the sales team is spread all over the major cities in China.
1996
The company hosted the founding conference of the Chinese Vascular Society in Shenzhen, laying a marketing model for academic promotion.
1997
The company co-organized the fourth National Vascular Surgery Conference of the Chinese Medical Association in Chongqing.
1998
The company introduced the treatment of male prostatic hyperplasia drug Saba brown soft capsule.
1999
The new product placenta polypeptide jointly developed by the company and the China Institute of Radiation Protection obtained the new drug certificate.
